Laboratoire de Biophotonique et Pharmacologie


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2005

10 mars 2009

A.Q. ABBADY, C. BRONNER, K. BATHAMI, C.D. MULLER, M. JEANBLANC, E. MATHIEU, J.P. KLEIN, E. CANDOLFI & M. MOUSLI. TCR pathway involves ICBP90 gene down-regulation via E2F1 binding sites. Biochem. Pharmacol. 70, 570-579, 2005

M. AHLOULAY, L. BANKIR, C. LUGNIER, A. LE BEC, O. POIREL, R. MOREAU & D. LEBREC. Cyclic AMP-phosphodiesterases inhibitor improves sodium excretion in rats with cirrhosis and ascites. Liver Int. 25, 403-409, 2005

P. ANDRE, C. METZGER, S. PETEY, D. MULLER & D. VIDON Chemiluminescence of enterococci isolates from freshwater. FEMS Microbiol. Lett. 245, 123-129, 2005

A. APPERT-COLLIN, F.H.T. DUONG, P. PASSILLY DEGRACE, J.M. WARTER, P. POINDRON & J.P. GIES. MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of Xaliproden. Int. J. Immunopathol. Pharmacol. 18, 21-31, 2005

A. APPERT-COLLIN, F.H.T. DUONG, P. PASSILLY DEGRACE, A. BENNASROUNE, P. POINDRON, J.M. WARTER & J.P. GIES. Xaliproden (SR57746A) induces 5-HT1A receptors-mediated MAP kinase activation in PC12 cells. Int. J. Immunopathol. Pharmacol. 18, 233-244, 2005

A.Q. ABBADY, C. BRONNER, K. BATHAMI, C.D. MULLER, M. JEANBLANC, E. MATHIEU, J.P. KLEIN, E. CANDOLFI & M. MOUSLI. TCR pathway involves ICBP90 gene down-regulation via E2F1 binding sites. Biochem. Pharmacol. 70, 570-579, 2005

Q.T. DO, I. RENIMEL, P. ANDRE, C. LUGNIER, C.D. MULLER & P. BERNARD. Reverse pharmacognosy : selnergy, a new tool for lead discovery. Curr. Drug Discov. Technol. 2, 161-167, 2005

G. FUHRMANN. Production de cellules germinales à partir de cellules souches embryonnaires de souris en culture. Derivation of germ cells from mouse embryonic stem cells. Gynecol. Obstet. Fertil. 33, 813-818, 2005

A. HAMADI, M. BOUALI, M. DONTENWILL, H. STOECKEL, K. TAKEDA & P. RONDE. Regulation of focal adhesion dynamics and disassembly by phosphorylation of FAK at tyrosine 397. J. Cell Sci. 118, 4415-4425, 2005

M. JEANBLANC, M. MOUSLI, R. HOPFNER, K. BATHAMI, N. MARTINET, A.Q. ABBADY, J.C. SIFFERT, E. MATHIEU, C.D. MULLER & C. BRONNER. The retinoblastoma gene and its product are targeted by ICBP90 : a key mechanism in the G1/S transition during the cell cycle. Oncogene 24, 7337-7345, 2005

T. KERAVIS, R. TAHSELDAR-ROUMIE & C. LUGNIER. Assessment of phosphodiesterase isozyme contribution in cell and tissue extracts. Meth. Mol. Biol. 307, 63-74, 2005

M. KRIER, J.X. DE ARAUJO-JUNIOR, M. SCHMITT, J. DURANTON, H. JUSTINIANO-BASARAN, C. LUGNIER, J.J. BOURGUIGNON & D. ROGNAN. Design of small-sized libraries by combinatorial assembly of linkers and functional groups to a given scaffold : application to the structure-based optimization of a phosphodiesterase 4 inhibitor. J. Med. Chem. 48, 3816-3822, 2005

A. LAGANA, J.G. GOETZ, N. Y, Y. ALTSCHULER & I.R. NABI. pH-specific sequestration of phosphoglucose isomerase/autocrine motility factor by fibronectin and heparan sulphate. J. Cell Sci. 118, 4175-4185, 2005

S. MARTIN, D.C. PHILLIPS, K. SZEKELY-SZUCS, L. ELGHAZI, F. DESMOTS & J.A. HOUGHTON. Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating Death-Induced Signaling Complex components into ceramide-enriched caveolae. Cancer Res. 65, 11447-11458, 2005

P. OHLMANN, A. TESSE, C. LOICHOT, H. RALAY RANAIVO, G. ROUL, C. PHILIPPE, D.M. WATTERSON, J. HAIECH & R. ANDRIANTSITOHAINA. Deletion of MLCK 210 induces subtle changes in vascular reactivity but does not affect cardiac function. Am. J. Physiol. 289, H2342-H2349, 2005

F. ORALLO, M. CAMINA, E. ALVAREZ, H. BASARAN & C. LUGNIER. Implication of cyclic nucleotide phosphodiesterase inhibition in the vasorelaxant activity of the citrus-fruits flavonoid (±)-naringenin. Planta Med. 71, 99-107, 2005

S. OUEDRAOGO, F. KINI, L. SERME, J.B. NIKIEMA, A. TRAORE, P.I. GUISSOU, M. NDIAYE, B. BUCHER & R. ANDRIANTSITOHAINA. Assessment of the hypotensive and vasodilator effects of extract and fractions from Odontoneme strictum (Acanthaceae). Ethnopharmacologia 36, 74-77, 2005

S. OUEDRAOGO, A. TRAORE, N. SOME, M. LOMPO, P.I. GUISSOU, C. SCHOTT, B. BUCHER & R. ANDRIANTSITOHAINA. Cardiovascular properties of aqueous extract from Tapinanthus dodoneifolius DC danser. Afr. J. Trad. 2, 25-30, 2005

T. PFITZER, N. NIEDERHOFFER & B. SZABO. Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system. N.-S. Arch. Pharmacol. 371, 9-17, 2005

J.M. REIMUND, G. RAHMI, G. ESCALIN, G. PINNA, G. FINCK, C.D. MULLER, B. DUCLOS & R. BAUMANN. Efficacy and safety of an olive oil-based intravenous fat emulsion in patients on home parenteral nutrition. Aliment Pharmacol. Ther. 21, 445-454, 2005

A. TESSE, M.C. MARTINEZ, B. HUGEL, K. CHALUPSKY, C.D. MULLER, F. MEZIANI, D. MITOLO-CHIEPPA, J.M. FREYSINNET & R. ANDRIANTSITOHAINA. Upregulation of proinflammatory proteins through NF-kB pathway by shed membrane microparticles results in vascular hyporeactivity. Arterioscler. Thromb. Vasc. Biol. 25, 2522-2527, 2005

B. WENIGER, A. LOBSTEIN, B.H. UM, C. VONTHRON-SENECHAU, R. ANTON, N. JIMENEZ USAGA, H. BASARAN & C. LUGNIER. Bioactive triterpenoids from Vochysia pacifica interact with cyclic nucleotide phosphodiesterase isozyme PDE4. Phytother. Res. 19, 75-77, 2005